Toll-like Receptor 4 and Vascular Cell Adhesion Molecule 1 in Monocyte-Endothelium Adhesion Induced by Lipopolysaccharide

Journal of Experimental and Clinical Medicine

Volumn 2, Issue 6, 2010, Pages 297-301

  Hung, Chia Hsiu ^a   Wu, Dean ^b   Lin, Feng Yen ^c   Yuan, Rey Yue ^d   Hu, Chaur Jong ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atherosclerosis; Lipopolysaccharide; Monocyte endothelium adhesion; Toll like receptor 4; VCAM 1

Indexed keywords

COMPLEMENTARY DNA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; UPREGULATION;

EID: 78650181145     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jecm.2010.10.003     Document Type: Article

References (23)

1. Mostaza J.M., Martín-Jadraque R., Vicente I., San Martin M.A., Lahoz C. Patients at high risk of cerebrovascular disease: the REACH study. Cerebrovasc Dis 2009, 27(Suppl 1)):77-81.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
3. Paoletti R., Gotto A.M., Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004, 109(23 Suppl 1):III 20-III 26.
4. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
5. Arancibia S.A., Beltrán C.J., Aguirre I.M., Silva P., Peralta A.L., Malinarich F., Hermoso M.A. Toll-like receptors are key participants in innate immune responses. Biol Res 2007, 40:97-112.
6. Vink A., Schoneveld A.H., Van der Meer J.J., Van Middelaar B.J., Sluijter J.P., Smeets M.B., Quax P.H., et al. In-vivo evidence of a role for toll-like receptor 4 in the development of intimal lesions. Circulation 2002, 106:1985-1990.
7. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., Akira S., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 2004, 101:10679-10684.
8. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
9. Lin Y.C., Chang Y.M., Yu J.M., Yen J.H., Chang J.G., Hu C.J. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 2005, 180:305-309.
10. Leinonen M., Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002, 2:11-17.
11. Kalayoglu M.V., Libby P., Byrne G.I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002, 288:2724-2731.
12. Heo S.K., Yun H.J., Noh E.K., Park W.H., Park S.D. LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production. Immunol Lett 2008, 120:57-64.
13. Triantafilou M., Gamper F.G., Lepper P.M., Mouratis M.A., Schumann C., Harokopakis E., Schifferle R.E., et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 2007, 9:2030-2039.
14. Barnett H.J.M., Mohr J.P., Stein B.M., Yatsu F.M. Stroke-Pathophysiology, Diagnosis and Management 1992, Churchill Livingstone, New York, 271-80. 2nd ed.
15. Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009, 335:191-203.
16. Kern J.M., Maass V., Maass M. Chlamydia pneumoniae-induced pathological signaling in the vasculature. FEMS Immunol Med Microbiol 2009, 55:131-139.
17. Stassen F.R., Vainas T., Bruggeman C.A. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 2008, 60:85-92.
18. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689-10692.
19. Dunzendorfer S., Lee H.K., Soldau K., Tobias P.S. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD 14 in mediating LPS responses. FASEB J 2004, 18:1117-1119.
20. Zeuke S., Ulmer A.J., Kusumoto S., Katus H.A., Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002, 56:126-134.
21. Hollestelle S.C., De Vries M.R., Van Keulen J.K., Schoneveld A.H., Vink A., Strijder C.F., Van Middelaar B.J., et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 2004, 109:393-398.
22. Andreakos E., Foxwell B., Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?. Immunol Rev 2004, 202:250-265.
23. Balogh S., Kiss I., Csaszar A. Toll-like receptors: link between 'danger' ligands and plaque instability. Curr Drug Targets 2009, 10:513-518.